Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP877069.RAbe_1fdIVLZK2Sz7McBp7OkeTpHcI5Z8CoPO0dDy315U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP877069.RAbe_1fdIVLZK2Sz7McBp7OkeTpHcI5Z8CoPO0dDy315U130_assertion type Assertion NP877069.RAbe_1fdIVLZK2Sz7McBp7OkeTpHcI5Z8CoPO0dDy315U130_head.
- NP877069.RAbe_1fdIVLZK2Sz7McBp7OkeTpHcI5Z8CoPO0dDy315U130_assertion description "[Furthermore, we observed that TSLC1 was methylated in 25 of 91 primary pancreatic adenocarcinomas (27%), and in 2 of 7 highgrade PanIN-3 lesions (29%), but not in low-grade PanIN (0 of 9 PanlN-2 and 0 of 30 PanIN-1) lesions or in normal pancreata (n=15).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP877069.RAbe_1fdIVLZK2Sz7McBp7OkeTpHcI5Z8CoPO0dDy315U130_provenance.
- NP877069.RAbe_1fdIVLZK2Sz7McBp7OkeTpHcI5Z8CoPO0dDy315U130_assertion evidence source_evidence_literature NP877069.RAbe_1fdIVLZK2Sz7McBp7OkeTpHcI5Z8CoPO0dDy315U130_provenance.
- NP877069.RAbe_1fdIVLZK2Sz7McBp7OkeTpHcI5Z8CoPO0dDy315U130_assertion SIO_000772 12432281 NP877069.RAbe_1fdIVLZK2Sz7McBp7OkeTpHcI5Z8CoPO0dDy315U130_provenance.
- NP877069.RAbe_1fdIVLZK2Sz7McBp7OkeTpHcI5Z8CoPO0dDy315U130_assertion wasDerivedFrom befree-20150227 NP877069.RAbe_1fdIVLZK2Sz7McBp7OkeTpHcI5Z8CoPO0dDy315U130_provenance.
- NP877069.RAbe_1fdIVLZK2Sz7McBp7OkeTpHcI5Z8CoPO0dDy315U130_assertion wasGeneratedBy ECO_0000203 NP877069.RAbe_1fdIVLZK2Sz7McBp7OkeTpHcI5Z8CoPO0dDy315U130_provenance.